Scientists Scan for Weaknesses in the SARS-CoV-2 Spike Protein

The virus’s tool for prying open host cells is coated in a protective armor of sugar—but gaps may offer vulnerability to disruption by antibodies.

chris baraniuk
| 5 min read
coronavirus sars-cov-2 spike protein covid-19 structure glycans ace2 furin antibody

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

ABOVE: © ISTOCK.COM, TRAFFIC_ANALYZER

Coronaviruses’ visual hallmarks, those nubby protrusions sticking out in every direction, are the keys they use to enter cells. These so-called spike proteins bind to cells—in the case of SARS-CoV-2, human cells—to launch infection. To prevent that from happening, scientists around the world are focusing on the spike to reveal how it works, and find potential weaknesses to exploit.

The spike structure itself is actually made up of three proteins. At the top lies the point at which the viral particle grasps an enzyme on the surface of human cells known as the ACE2 receptor.

This point must be in an “open” or “up” position, flexed and ready to attach itself to the host cell receptor, says Rommie Amaro, a biophysical chemist at the University of California, San Diego. An animation posted online by Greg Bowman, a biophysicist at Washington University School of Medicine, reveals that ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • chris baraniuk

    Chris Baraniuk

    Chris Baraniuk is a freelance science journalist based in Northern Ireland who contributes to The Scientist.
Share
TS Digest January 2025
January 2025, Issue 1

Why Do Some People Get Drunk Faster Than Others?

Genetics and tolerance shake up how alcohol affects each person, creating a unique cocktail of experiences.

View this Issue
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo
New Frontiers in Vaccine Development

New Frontiers in Vaccine Development

Sino
New Approaches for Decoding Cancer at the Single-Cell Level

New Approaches for Decoding Cancer at the Single-Cell Level

Biotium logo
Learn How 3D Cell Cultures Advance Tissue Regeneration

Organoids as a Tool for Tissue Regeneration Research 

Acro 

Products

Artificial Inc. Logo

Artificial Inc. proof-of-concept data demonstrates platform capabilities with NVIDIA’s BioNeMo

Sapient Logo

Sapient Partners with Alamar Biosciences to Extend Targeted Proteomics Services Using NULISA™ Assays for Cytokines, Chemokines, and Inflammatory Mediators

Bio-Rad Logo

Bio-Rad Extends Range of Vericheck ddPCR Empty-Full Capsid Kits to Optimize AAV Vector Characterization

Scientist holding a blood sample tube labeled Mycoplasma test in front of many other tubes containing patient samples

Accelerating Mycoplasma Testing for Targeted Therapy Development